Mark Stearman is a seasoned professional with over thirty years of experience in clinical diagnostics, particularly focused on innovations for patients living with Alzheimer’s Disease. Currently serving as the Senior Brand Manager for Alzheimer’s Diagnostics at Eli Lilly and Company, they continue to drive the development of diagnostic solutions. Previously, as a Senior International Product Manager at Roche, Mark played a key role in enhancing the diagnostic journey for Alzheimer’s patients and promoting personalized healthcare solutions. With advanced degrees in healthcare business and immunology, Mark's expertise spans immuno-diagnostics and cardiology, showcasing a commitment to improving patient outcomes in the clinical field.
This person is not in any teams
This person is not in any offices